Where is the Delta variant? According to the vaccine industry’s own definition, “the human papillomavirus (HPV) vaccine is available in two forms: covid-1 and covid-2. The vaccines are designated as having separate formulations based on their individual activity on the HPV virus.” This is an accurate description, but it is also a bit misleading. Where is the Delta vaccine supposed to be used? Assuming it is being used for severe disease prevention only, then the two formulations should be identical.
In other words, there should be no difference between the two doses of vaccine, and any symptoms that occur after the first dose of either should be treated as a severe disease and moved to the top of the list of symptoms to be treated with an enhanced preventive vaccination. Otherwise, the second dose of the covid-19 vaccine could cause adverse events to occur, which would lead to a loss of points toward vaccine coverage.
How long is it supposed to be prevented from infecting an in-vaccinated person? From the perspective of the FDA and the pharmaceutical companies, the intended purpose of the two formulations is to provide protection throughout the interval between exposure and onset of disease, but this is a rather vague definition. To some observers, the intended use is quite literal: prevent hepatitis B and C viruses from causing serious disease in un-vaccinated individuals.
And while there are ongoing studies at various universities that will provide more specific data on the temporal association of the two formulations, it appears that there is a difference between preventing hepatitis B and C in vaccinated individuals and those not vaccinated. For example, there was a recent study showing that there may be a protective effect in un-vaccinated individuals against hepatitis B; however, this effect did not extend to the elderly or to women.
Why aren’t we told CNN about the delta variant? There are a few reasons for this. One is that the medical community does not view the vaccines as having high incidence rates among vaccinated individuals. The other reason is that the medical community is not familiar with this variation. If there was ever an incidence of an outbreak in which a large percentage of the patients were vaccinated, it would probably be covered by the flu shots. Why was the epidemic stopped after being contained?
The CDC was asked why the outbreak wasn’t longer occurring. They answered that the only real way to stop a severe disease like this from spreading is if everyone who could be exposed took a dose of the vaccine. Since there are no plans to make a vaccine for the transmissible delta virus, and since it is very unlikely that the rate of incidence will be anywhere near what it was in countries with adequate vaccination coverage, there is no immediate concern.
How was the vaccine made safe and effective? This is a tricky question. The manufacturing facilities for the vaccine are required to follow very strict guidelines for making sure that the products are as safe as possible. Any problems or concerns with the manufacturing process should be brought to the attention of the FDA. They have set standards by which they inspect vaccines to ensure that they are free of any problems. This is one of the steps that the FDA has taken to ensure that the deaths from the virus were stopped at the very beginning and there were no lapses in the safety of the vaccine.